viernes, 16 de octubre de 2009

Target HbA1c levels still the subject of much debate, but tailored therapy should be the aim

Oct 9, 2009
Lisa Nainggolan

Vienna, Austria - Leading diabetes doctors are still discussing where the target for glycated hemoglobin A1c (HbA1c) levels in type 2 diabetes should ideally be set, with one camp calling for a goal of 6.5% or lower, while the other group says 7% or even higher is a reasonable aim. The topic was debated in front of a packed audience at the European Association for the Study of Diabetes (EASD) 2009 Meeting last week and was a hot topic of conversation throughout the meeting.
In the wake of all data available today, diabetologists are still trying to tease out the best message to convey to primary-care physicians and other nonspecialists who might be treating patients with type 2 diabetes. And although there is still disagreement, a truce of sorts was agreed upon in Vienna: that targeting therapy to the individual patient is the ideal way to approach diabetes management.

No hay comentarios:

Publicar un comentario